Main Session
Sep
30
SS 42 - Gyn 4: GYN Clinical Trials - Challenging the paradigm in gynecologic cancers
343 - Phase 3 Study of Pembrolizumab (Pembro) + Adjuvant Chemotherapy (CT) ± Radiotherapy (RT) for Newly Diagnosed, High-Risk Endometrial Cancer (EC): Exploratory Analysis of Disease-Specific-Free Survival (DSFS) and Safety by Radiation Usage
Presenter(s)
Jyoti Mayadev, MD, FASTRO - UCSD, La JOlla, CA